Amazing. This ad as found on MDLinx.com's cardiology section for Lilly's Effient (prasugrel) before the drug's even approved by the FDA and despite the controversy swirling around about their advisory panel's approval meeting.
Lilly wouldn't have an inside line, would they?
-Wes
Ahhh, from what I'm told, the FDA pretty much depends on drug companies to regulate themselves anyway. Hopefully that'll all change with the new administration.
ReplyDeleteEli Lilly can kill and maim thousands of people with Zyprexa, be held criminally liable for it, pay out millions in fines for other offenses, and this surpises you? Not me. Not in the least.
ReplyDeleteIt sickens me, but it doesn't surprise me.
This post on Gene Sherpas is kind of interesting:
ReplyDeletehttp://thegenesherpa.blogspot.com/2009/02/prasugrel-saves-clopidogrel.html
There's a story on theheart.org on the advisory committee meeting:
ReplyDelete"Red flags raised over FDA advisory-panel hearing on prasugrel"
http://www.theheart.org/article/941619.do
just wanted to say hello! i found your blog on chicago's best blogs, since we're both listed on the life and style page.
ReplyDeletesee ya around!